Patents Assigned to INSERM (Institu National de la Sante et de la Recherche Medicale)
  • Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
    Publication number: 20120177688
    Abstract: The present invention relates to a life attenuated Bordetella pertussis vaccine which is deficient for tracheal cytotoxin (TCT), pertussis toxin (PTX), and dermonecrotic toxin (DNT) for prophylaxis or treatment of an allergen-driven airway pathology.
    Type: Application
    Filed: April 26, 2010
    Publication date: July 12, 2012
    Applicants: INSTITUT PASTEUR DE LILLE, INSERM (Institu National de la Sante et de la Recherche Medicale), NATIONAL UNIVERSITY OF IRELAND MAYNOOTH
    Inventors: Camille Locht, Bernard Mahon, Heather Kavanagh